title: Autoimmune and inflammatory responses may have an additive effect in postpercutaneous transluminal coronary angioplasty restenosis.
abstract: Patients who had an increase in their serum amyloid type A level of > 100% in the first 24 hours after percutaneous transluminal coronary angioplasty (PTCA) and also developed a positive antibody result (antinuclear factor or anticardiolipin), had a relative risk of 10.6 for developing restenosis in the first year after PTCA.
authors.affiliation: Department of Cardiology, Tel-Aviv Medical Center, Sackler Medical School, Tel-Aviv University, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Blum
authors.forename: N
authors.initials: N
authors.lastname: Vardinon
authors.forename: G
authors.initials: G
authors.lastname: Kaplan
authors.forename: S
authors.initials: S
authors.lastname: Laniado
authors.forename: I
authors.initials: I
authors.lastname: Yust
authors.forename: M
authors.initials: M
authors.lastname: Burk
authors.forename: H
authors.initials: H
authors.lastname: Miller
mesh_terms: D000789:Angina, Unstable / Q000276:immunology* / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000917:Antibody Formation; D001323:Autoantibodies; D015551:Autoimmunity; D003251:Constriction, Pathologic; D005260:Female; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D000685:Serum Amyloid A Protein / Q000032:analysis
chemical_list: D001323:Autoantibodies; D000685:Serum Amyloid A Protein